Clinical Trial Update: Safety and Efficacy of Fludarabine and Cyclophosphamide + Rituximab [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the safety and efficacy of fludarabine with cyclophosphamide and rituximab in Follicular lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Fludarabine (Fludarabine)
• Rituximab (rituximab)

Snippet

Sponsor: Gruppo Italiano Studio Linfomi | Conditions: Follicular Lymphoma | Phase 2 | Status: COMPLETED